Dr. Agarwal's Health Care Limited (NSE:AGARWALEYE)
India
· Delayed Price · Currency is INR 448.05
-1.25 (-0.28%)
Mar 10, 2026, 1:09 PM IST
Dr. Agarwal's Health Care Revenue
Dr. Agarwal's Health Care had revenue of 5.30B INR in the quarter ending December 31, 2025, with 23.02% growth. This brings the company's revenue in the last twelve months to 19.76B, up 23.53% year-over-year. In the fiscal year ending March 31, 2025, Dr. Agarwal's Health Care had annual revenue of 17.11B with 28.44% growth.
Revenue (ttm)
19.76B
Revenue Growth
+23.53%
P/S Ratio
7.20
Revenue / Employee
n/a
Employees
n/a
Market Cap
142.34B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 17.11B | 3.79B | 28.44% |
| Mar 31, 2024 | 13.32B | 3.14B | 30.86% |
| Mar 31, 2023 | 10.18B | 3.22B | 46.25% |
| Mar 31, 2022 | 6.96B | 2.25B | 47.73% |
| Mar 31, 2021 | 4.71B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 568.09B |
| Divi's Laboratories | 103.14B |
| Apollo Hospitals Enterprise | 242.15B |
| Cipla | 279.67B |
| OneSource Specialty Pharma | 14.19B |
| Syngene International | 37.20B |
| Alembic Pharmaceuticals | 72.67B |
| Concord Biotech | 11.59B |